News | October 02, 2007

New Retrievable IVC Filter Implanted in U.S.

October 3, 2007 - Crux Biomedical Inc., a medical device firm, announced it recently completed the first implant in the United States of the Crux IVC Filter, as part of its strategy to deliver an inferior vena cava filter (IVC) that better meets physicians’ needs.

The filter is used to prevent pulmonary embolism (PE) and is designed to provide self-centering, ease of retrieval and low profile. Crux’s IVC filter was implanted at the Atlanta Medical Center by David Rosenthal, M.D., chief of Vascular Surgery. Dr. Rosenthal is the Principal Investigator for Crux’s pivotal IDE study, which is being conducted at 12 leading medical institutions in the United States.

Annual sales of IVC filter in the United States are estimated to be $252MM in 2008 and growing between 8-10% annually. Filters are increasingly being used as a result of increased diagnosis of deep vein thrombosis and the protection that they afford in cases of trauma and orthopedic surgeries.

For more information: www.cruxbiomedical.com

Related Content

Florida Law Firm Sues Cordis, Blames Death on IVC Filter
News | Vena Cava Filters | January 02, 2018
January 2, 2018 — Osborne & Associates Law Firm, P.A., of Boca Raton, Fla., has filed suit in Palm Beach Circuit
News | Vena Cava Filters | September 26, 2017
September 26, 2017 — The one-year results of the SENTRY...
Videos | Vena Cava Filters | July 24, 2012
This video, provided by Crux Biomedical, demonstrates the implantation of the FDA-cleared Crux VCF inferior vena cava
Videos | Vena Cava Filters | April 06, 2012
The Crux inferior vena cava (IVC) filter was designed for easy deployment and later retrieval.
Videos | Vena Cava Filters | April 06, 2012
The Crux inferior vena cava (IVC) filter was designed for easy deployment and later retrival.
Overlay Init